Authorizes the Secretary of Health and Human Services to reimburse states fully for expenditures associated with the implementation of the Medicare prescription drug benefit for dual eligible individuals.
[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4663 Introduced in House (IH)]
109th CONGRESS
2d Session
H. R. 4663
To authorize the Secretary of Health and Human Services to reimburse
States for expenditures associated with the implementation of the
Medicare prescription drug benefit for dual eligible individuals.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 31, 2006
Mr. Bradley of New Hampshire introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To authorize the Secretary of Health and Human Services to reimburse
States for expenditures associated with the implementation of the
Medicare prescription drug benefit for dual eligible individuals.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. AUTHORIZATION OF STATE REIMBURSEMENT FOR EXPENDITURES
ASSOCIATED WITH THE IMPLEMENTATION OF THE MEDICARE
PRESCRIPTION DRUG BENEFIT FOR DUAL ELIGIBLE INDIVIDUALS.
(a) In General.--Notwithstanding section 1935(d) of the Social
Security Act (42 U.S.C. 1396u-5(d)) or any other provision of law, with
respect to covered part D drugs (as defined in section 1860D-2(e) of
such Act (42 U.S.C. 1395w-102(e)) for full-benefit dual eligible
individuals (as defined in section 1935(c)(6) of such Act (42 U.S.C.
1396u-5(c)(6)) who are enrolled in a prescription drug plan under part
D of title XVIII of such Act (or an MA-PD plan under part C of such
title), the Secretary of Health and Human Services is authorized to
fully reimburse a State (as defined for purposes of title XIX of such
Act) for the costs described in subsection (b).
(b) Costs Described.--For purposes of subsection (a), costs
described in this subsection are costs incurred by the State as a
result of the implementation of any program, with respect to access to
covered part D drugs for individuals described in subsection (a), that
is consistent with the guidance to States issued by the Centers of
Medicare & Medicaid on January 14, 2006, titled ``Transitional State--
Part D Plan Coordination of Benefits'', without regard to the date of
implementation of the program or the duration of the program. Such
costs include copayments made on behalf of such individuals,
administrative costs, and costs associated with disputed claim
reconciliation.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line